Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126954991 | 12695499 | 1 | I | 20110207 | 20110210 | 20160829 | 20160829 | EXP | US-PFIZER INC-2011029464 | PFIZER | 64.00 | YR | F | Y | 82.00000 | KG | 20160829 | MD | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126954991 | 12695499 | 1 | PS | IBUPROFEN. | IBUPROFEN | 1 | Oral | UNK UNK, 3X/DAY | Y | 18989 | TABLET | TID | |||||||
126954991 | 12695499 | 2 | SS | IBUPROFEN. | IBUPROFEN | 1 | Y | 18989 | TABLET | ||||||||||
126954991 | 12695499 | 3 | SS | HYDROCHLOROTHIAZIDE/LISINOPRIL | HYDROCHLOROTHIAZIDELISINOPRIL | 1 | Oral | 20/25 MG, DAILY | Y | 0 | |||||||||
126954991 | 12695499 | 4 | C | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | 20 OR 40 MG ONCE DAILY | 0 | QD | |||||||||
126954991 | 12695499 | 5 | C | BENICAR HCT | HYDROCHLOROTHIAZIDEOLMESARTAN MEDOXOMIL | 1 | Oral | 20/12.5 MG ONCE DAILY | 0 | QD | |||||||||
126954991 | 12695499 | 6 | C | VITAMIN D | CHOLECALCIFEROL | 1 | Oral | 4000 MEQ, 1X/DAY | 0 | 4000 | MEQ | QD | |||||||
126954991 | 12695499 | 7 | C | FISH OIL | FISH OIL | 1 | Oral | 1200 MG, 1X/DAY | 0 | 1200 | MG | QD | |||||||
126954991 | 12695499 | 8 | C | CALCIUM | CALCIUM | 1 | Oral | ONCE DAILY | 0 | QD | |||||||||
126954991 | 12695499 | 9 | C | PRAVASTATIN. | PRAVASTATIN | 1 | Oral | 40 MG, 1X/DAY | 0 | 40 | MG | QD | |||||||
126954991 | 12695499 | 10 | C | TRAMADOL HYDROCHLORIDE. | TRAMADOL HYDROCHLORIDE | 1 | Oral | 50 MG, 3X/DAY | 0 | 50 | MG | TID | |||||||
126954991 | 12695499 | 11 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | Oral | 25 UG, 1X/DAY | 0 | 25 | UG | QD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126954991 | 12695499 | 1 | Osteoarthritis |
126954991 | 12695499 | 2 | Rheumatoid arthritis |
126954991 | 12695499 | 3 | Hypertension |
126954991 | 12695499 | 4 | Prophylaxis |
126954991 | 12695499 | 5 | Hypertension |
126954991 | 12695499 | 6 | Supplementation therapy |
126954991 | 12695499 | 7 | Supplementation therapy |
126954991 | 12695499 | 8 | Supplementation therapy |
126954991 | 12695499 | 9 | Dyslipidaemia |
126954991 | 12695499 | 10 | Arthritis |
126954991 | 12695499 | 11 | Hypothyroidism |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126954991 | 12695499 | HO |
126954991 | 12695499 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126954991 | 12695499 | Hypotension | |
126954991 | 12695499 | Renal failure |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126954991 | 12695499 | 1 | 20100305 | 20110207 | 0 | |
126954991 | 12695499 | 3 | 20100212 | 0 | ||
126954991 | 12695499 | 4 | 20100303 | 0 | ||
126954991 | 12695499 | 5 | 20100403 | 0 | ||
126954991 | 12695499 | 6 | 20100125 | 0 | ||
126954991 | 12695499 | 7 | 200907 | 0 | ||
126954991 | 12695499 | 8 | 200907 | 0 | ||
126954991 | 12695499 | 9 | 20100427 | 0 | ||
126954991 | 12695499 | 10 | 20110104 | 0 | ||
126954991 | 12695499 | 11 | 20090725 | 0 |